在细胞重编程中,先驱转录因子和表观遗传修饰剂之间的相互作用
Gerardo Mirizio1,2, Samuel Sampson1,2, Makiko Iwafuchi1,2
1Division of Developmental Biology, Center for Stem Cell & Organoid Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, USA.
Regenerative therapy
|January 21, 2025
概括
先进的转录因子 (TFs) 驱动细胞重编程,包括直接细胞转化. 了解它们与表观遗传修饰物的相互作用是提高临床使用重编程效率的关键.
科学领域:
- 细胞重编程和表观遗传学.
背景情况:
- 先驱转录因子 (TFs) 对于诱导多能干细胞 (iPSC) 生成和直接细胞重编程至关重要.
- 这些TF通过打开染色质来启动重编程,使新的基因表达程序成为可能.
- 直接重编程的效率目前在临床应用中是有限的.
研究的目的:
- 审查先TF驱动重编程的分子机制.
- 专注于先驱TF和表观遗传修饰剂之间的相互作用.
主要方法:
- 关于重编程中的先驱TF函数的文献综述.
- 分析与表观遗传调节剂的相互作用,如多镇压复合物 (PRC),核细胞重塑和脱乙酶 (NuRD) 复合物,以及DNA甲基化机制.
主要成果:
- 开拓者TFs通过染色体开放启动重新编程.
- 开拓者TF活动受到表观遗传调节的影响,并影响表观遗传调节.
- 与表观遗传修饰物的相互作用是重编程过程的核心.
结论:
- 了解先驱TF和表观遗传修饰剂之间的相互作用对于推进重编程技术至关重要.
- 通过这种理解来提高重编程效率将增强临床应用.
相关概念视频
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Chromatin Modification in iPS Cells
1.6K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.6K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
RNA Polymerase II Accessory Proteins
9.1K
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
9.1K
Combinatorial Gene Control
8.3K
Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
8.3K
Transcription Factors
75.6K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
75.6K


